Thrombosis risk factor modifications: Difference between revisions
No edit summary |
Shyam Patel (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Thrombosis}} | {{Thrombosis}} | ||
{{CMG}} {{shyam}} | |||
In patients with known risk factor(s) of thrombosis formation | ==Thrombosis risk factor modifications== | ||
In patients with known risk factor(s) of thrombosis formation, risk factor modification may be necessary for preventive purposes. Cost-effect analysis must be taken into account. The prevention process starts by prescribing anti-coagulant and anti-platelet drugs. For instance, the thrombosis prevention pharmacotherapy is routinely administered after major surgical procedures and in patients with hypercoagulability like antiphospholipid syndrome. | |||
===Behavioral modifications=== | |||
*'''Weight loss''': Obesity is a risk factor for thrombosis since adipose tissue produces estrogen, which is pro-thrombotic. Also, obesity contributes to relative immobility and venous stasis, which is a risk factor for thrombosis. | |||
*'''Smoking cessation''': Smoking is a risk factor for thrombosis because it contributes to endothelial damage. | |||
*'''Exercise''': Regular cardiovascular exercise improves blood flow and prevents venous stasis. Exercise is a prophylactic measure against the development of thrombosis. | |||
==References== | ==References== | ||
Revision as of 22:16, 30 December 2018
|
Thrombosis Microchapters |
|
Site of Thrombosis |
|---|
|
Differentiating Thrombosis from other Diseases |
|
Diagnosis |
|
Treatment |
|
Thrombosis risk factor modifications On the Web |
|
Risk calculators and risk factors for Thrombosis risk factor modifications |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Shyam Patel [2]
Thrombosis risk factor modifications
In patients with known risk factor(s) of thrombosis formation, risk factor modification may be necessary for preventive purposes. Cost-effect analysis must be taken into account. The prevention process starts by prescribing anti-coagulant and anti-platelet drugs. For instance, the thrombosis prevention pharmacotherapy is routinely administered after major surgical procedures and in patients with hypercoagulability like antiphospholipid syndrome.
Behavioral modifications
- Weight loss: Obesity is a risk factor for thrombosis since adipose tissue produces estrogen, which is pro-thrombotic. Also, obesity contributes to relative immobility and venous stasis, which is a risk factor for thrombosis.
- Smoking cessation: Smoking is a risk factor for thrombosis because it contributes to endothelial damage.
- Exercise: Regular cardiovascular exercise improves blood flow and prevents venous stasis. Exercise is a prophylactic measure against the development of thrombosis.